Catalyst Pharmaceuticals (CPRX) Accounts Payables (2010 - 2026)
Catalyst Pharmaceuticals' (CPRX) quarterly Accounts Payables came in at $7.2 million in Q1 2026, down 36.13% YoY from $11.2 million in Q1 2025, and down 36.16% on a QoQ basis from $11.2 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Accounts Payables (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 17 years of Accounts Payables data on file, last reported at $7.2 million in Q1 2026.
- Quarterly Accounts Payables fell 36.13% year-over-year to $7.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.2 million (down 36.13% YoY) and the FY2025 annual result came in at $11.2 million, down 32.49% from the prior year.
- Accounts Payables fell to $7.2 million in Q1 2026, from $11.2 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $16.6 million in Q4 2024 to a low of $2.3 million in Q2 2022.
- A 5-year average of $7.7 million and a median of $7.1 million in 2024 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2023 — Accounts Payables soared 272.2% — and 2026, when it plunged 36.13%.
- Tracing CPRX's Accounts Payables over 5 years: stood at $4.0 million in 2022, then soared by 272.2% to $14.8 million in 2023, then advanced by 12.15% to $16.6 million in 2024, then plunged by 32.49% to $11.2 million in 2025, then slumped by 36.16% to $7.2 million in 2026.
- The last three Accounts Payables figures came in at $7.2 million (Q1 2026), $11.2 million (Q4 2025), and $9.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 7.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.15 Mn |
| Dec 31, 2025 | 11.20 Mn |
| Sep 30, 2025 | 9.10 Mn |
| Jun 30, 2025 | 5.53 Mn |
| Mar 31, 2025 | 11.20 Mn |
| Dec 31, 2024 | 16.59 Mn |
| Sep 30, 2024 | 11.56 Mn |
| Jun 30, 2024 | 7.12 Mn |
| Mar 31, 2024 | 10.26 Mn |
| Dec 31, 2023 | 14.80 Mn |
| Sep 30, 2023 | 4.60 Mn |
| Jun 30, 2023 | 4.42 Mn |
| Mar 31, 2023 | 3.39 Mn |
| Dec 31, 2022 | 3.98 Mn |
| Sep 30, 2022 | 2.53 Mn |
| Jun 30, 2022 | 2.32 Mn |
| Mar 31, 2022 | 5.14 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Sep 30, 2021 | 2.75 Mn |
| Jun 30, 2021 | 2.92 Mn |